Abstract
It has been hypothesized that dysregulation of brain-expressed genes is the major predisposing underlying mechanism for autism. This dysregulation may be mediated by differential methylation of CpG sites within gene promoters, which could be candidate biomarkers and used for early clinical screening of autism. A total of 131 pairs of age- and sex-matched autistic and control subjects were recruited in this study. Peripheral blood cells were analyzed. The first five pairs were randomly applied to array-based genome-wide methylation studies. A neuron-specific gene, ENO2, was found to be hypermethylated in the autistic samples. This difference was validated by bisulfite sequencing PCR (BSP). The differential expression of ENO2 gene was further analyzed with RT-qPCR and ELISA. The hypermethylation of ENO2 within the promoter region was confirmed by BSP to be present in 14.5 % (19/131) of the total of the autistic samples. The mean ENO2 RNA level in these 19 autistic samples was reduced by about 70 % relative to that in controls. The average level of ENO2 protein expression in the 19 autistic samples (15.18 ± 3.51 μg/l) was about half of that in the controls (33.86 ± 8.16 μg/l). Conclusion: These findings suggest that reduced ENO2 expression may be a biomarker for a subset of autistic children.Electronic supplementary materialThe online version of this article (doi:10.1007/s00431-014-2311-9) contains supplementary material, which is available to authorized users.
Highlights
Autism comprises a clinically and genetically heterogeneous group of disorders with a complex etiology
We have focused on the hypermethylation and the differential expression of gene ENO2
There were 228 genes differentially methylated in the promoter regions and 247 genes in CpG islands in the five pairs analyzed by the Methylated DNA immunoprecipitation (MeDIP) method when 1.5-fold and p
Summary
Autism comprises a clinically and genetically heterogeneous group of disorders with a complex etiology. It is characterized by impairments in reciprocal social communication and the presence of restricted, repetitive, and stereotyped patterns of behavior [5, 31]. Autism occurs predominantly in males, with a ratio of males to females of about 4 to 1 It is a leading cause of childhood disability and inflicts serious suffering and financial burdens for the family and the society [4]. Studies have been carried out to identify candidate biomarker(s) associated with the development of autism. Momeni et al [14] identified differentially expressed peptides that were fragments of the C3 complement protein and could potentially serve as a set of biomarkers for the early detection of autism. The differential expression of some of these genes may result from epigenetic modifications [18]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
